T. Shigeta et al., Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations, CANCER RES, 59(11), 1999, pp. 2602-2607
Ataxia telangiectasia (AT) carrier-derived :lymphoblastoid cell lines (AT-L
CLs/hetero) with suboptimal ATM protein expression were examined for the re
gulation of radiosensitivity, apoptosis, and mitotic spindle checkpoint in
response to DNA-damaging agents. Although AT-LCLs/hetero showed intermediat
e radiation sensitivity, as determined by clonogenic assay, they were resis
tant to early-onset apoptosis, as much as AT patient-derived LCLs (AT-LCLs/
homo) Furthermore, two of three AT-LCLs/hetero shelved defective mitotic sp
indle checkpoint control in response to X-ray irradiation, which is, a rece
ntly characterized biological feature in AT-LCLs/homo, Our findings indicat
e that carriers of ATM mutation have biological abnormalities due to haploi
nsufficiency of ATM protein or dominant-negative effect of mutant ATM prote
in. Thus, although it is still controversial whether ATM mutation carriers
are at higher risk for cancer during adulthood, our findings based on in vi
tro biological indicators support the notion that at least some of such car
riers are at a higher risk for cancer development than those without ATM mu
tation. Oar findings may help to reevaluate epidemiological studies on canc
er susceptibility in AT carriers.